Skip to main content
. 2013 Jan 8;14(1):1093–1104. doi: 10.3390/ijms14011093

Table 3.

Number and percentages of c-erbB2 (Her2)-switches between primary tumor and circulating tumor cells (CTCs).

Her2 Status Tumor/CTCs Adjuvant Metastatic


Number % Number %
+/+ 3/14 22% 1/11 9%
+/− 1/14 7% 6/11 55%
−/+ 6/14 43% 1/11 9%
−/− 4/14 28% 3/11 27%